{
  "trial_id": "NCT03529955",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Must understand the risks and the benefits/purpose of the study",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Must be 18 years at time of signing the informed consent form",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Willing to participate in all required evaluations and procedures in the study",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients must have a diagnosis of DM based upon the characteristic cutaneous findings proposed by Sontheimer[6] and/or a skin biopsy consistent with DM",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients must be candidate for systemic therapy for their DM skin disease defined by inadequate response to aggressive sun protection along with the use of potent topical corticosteroids and/or immunomodulators",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Increasing or changing dose of topical therapy within 14 days of study day 0",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "History of any clinically significant (as determined by the investigators) cardiac, endocrinologic, pulmonary, neurologic, psychiatric, hepatic, renal, hematologic, immunologic, or other major uncontrolled disease",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of severe 'exploding' headache and abnormal vasculature with a draining vein from L temporal lobe consistent with AVM. She was discharged to home with her husband on [**2155-12-6**].",
  "_meta": {
    "topic_id": "3",
    "trial_id": "NCT03529955",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}